

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.54590178 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54590178 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.28138409 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.28138409 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 6.03814455 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.91460764 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.69217515 |
| 8 | complement activation, alternative pathway (GO:0006957) | 5.18021493 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 5.14859549 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.13428495 |
| 11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.06000183 |
| 12 | regulation of triglyceride catabolic process (GO:0010896) | 5.04865749 |
| 13 | urea cycle (GO:0000050) | 5.03861766 |
| 14 | urea metabolic process (GO:0019627) | 5.03861766 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.99259815 |
| 16 | glyoxylate metabolic process (GO:0046487) | 4.96051830 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.95559313 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.95559313 |
| 19 | tryptophan catabolic process (GO:0006569) | 4.95559313 |
| 20 | cysteine metabolic process (GO:0006534) | 4.95180888 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.80265502 |
| 22 | protein carboxylation (GO:0018214) | 4.79617513 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.79617513 |
| 24 | regulation of protein activation cascade (GO:2000257) | 4.69584516 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 4.69428709 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.67846127 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.64596104 |
| 28 | plasma lipoprotein particle clearance (GO:0034381) | 4.62244592 |
| 29 | acylglycerol homeostasis (GO:0055090) | 4.49211923 |
| 30 | triglyceride homeostasis (GO:0070328) | 4.49211923 |
| 31 | bile acid metabolic process (GO:0008206) | 4.48928759 |
| 32 | regulation of complement activation (GO:0030449) | 4.44113930 |
| 33 | lysine catabolic process (GO:0006554) | 4.43732993 |
| 34 | lysine metabolic process (GO:0006553) | 4.43732993 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.41279201 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.40197330 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 4.38389526 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.31183792 |
| 39 | phospholipid efflux (GO:0033700) | 4.28560237 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.25989286 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.25989286 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.25989286 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.24807364 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.23462850 |
| 45 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.22036681 |
| 46 | valine metabolic process (GO:0006573) | 4.21843027 |
| 47 | ethanol oxidation (GO:0006069) | 4.18565431 |
| 48 | positive regulation of lipid catabolic process (GO:0050996) | 4.14186830 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.11299959 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.11299959 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.09824621 |
| 52 | acetyl-CoA metabolic process (GO:0006084) | 4.09803458 |
| 53 | aromatic amino acid family metabolic process (GO:0009072) | 4.07831763 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.07461699 |
| 55 | fatty acid beta-oxidation (GO:0006635) | 4.05727786 |
| 56 | COPI coating of Golgi vesicle (GO:0048205) | 4.00869246 |
| 57 | Golgi transport vesicle coating (GO:0048200) | 4.00869246 |
| 58 | low-density lipoprotein particle clearance (GO:0034383) | 3.97731891 |
| 59 | * fatty acid oxidation (GO:0019395) | 3.86717098 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 3.85808674 |
| 61 | phospholipid homeostasis (GO:0055091) | 3.84311717 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 3.84211869 |
| 63 | plasma lipoprotein particle assembly (GO:0034377) | 3.83123485 |
| 64 | cholesterol efflux (GO:0033344) | 3.82376844 |
| 65 | fatty acid catabolic process (GO:0009062) | 3.81833467 |
| 66 | coenzyme catabolic process (GO:0009109) | 3.81669449 |
| 67 | * lipid oxidation (GO:0034440) | 3.78803547 |
| 68 | short-chain fatty acid metabolic process (GO:0046459) | 3.78060285 |
| 69 | bile acid and bile salt transport (GO:0015721) | 3.75932440 |
| 70 | glycine metabolic process (GO:0006544) | 3.75446398 |
| 71 | fatty acid transmembrane transport (GO:1902001) | 3.75251461 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 3.72992881 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71884497 |
| 74 | negative regulation of lipase activity (GO:0060192) | 3.71580086 |
| 75 | proline biosynthetic process (GO:0006561) | 3.70747890 |
| 76 | monocarboxylic acid catabolic process (GO:0072329) | 3.68430670 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68419754 |
| 78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68419754 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 3.64682677 |
| 80 | cholesterol homeostasis (GO:0042632) | 3.63750509 |
| 81 | glutamate metabolic process (GO:0006536) | 3.62127591 |
| 82 | positive regulation of fatty acid oxidation (GO:0046321) | 3.61745200 |
| 83 | regulation of sequestering of triglyceride (GO:0010889) | 3.60329831 |
| 84 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.60265706 |
| 85 | triglyceride catabolic process (GO:0019433) | 3.59579263 |
| 86 | cellular glucuronidation (GO:0052695) | 3.59470862 |
| 87 | organic acid catabolic process (GO:0016054) | 3.59291344 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 3.59291344 |
| 89 | sterol homeostasis (GO:0055092) | 3.58860806 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 3.57823030 |
| 91 | acylglycerol catabolic process (GO:0046464) | 3.56449760 |
| 92 | neutral lipid catabolic process (GO:0046461) | 3.56449760 |
| 93 | protein-lipid complex assembly (GO:0065005) | 3.55776120 |
| 94 | biotin metabolic process (GO:0006768) | 3.54171998 |
| 95 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.53461850 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.53418465 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.49849990 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.47378950 |
| 99 | carnitine metabolic process (GO:0009437) | 3.46663814 |
| 100 | indolalkylamine metabolic process (GO:0006586) | 3.43362551 |
| 101 | desmosome organization (GO:0002934) | 3.43027454 |
| 102 | NADH metabolic process (GO:0006734) | 3.42812916 |
| 103 | complement activation (GO:0006956) | 3.42481291 |
| 104 | plasma lipoprotein particle organization (GO:0071827) | 3.41892687 |
| 105 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.41467996 |
| 106 | negative regulation of fatty acid transport (GO:2000192) | 3.40473720 |
| 107 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.39966776 |
| 108 | focal adhesion assembly (GO:0048041) | 3.28713760 |
| 109 | cell-substrate adherens junction assembly (GO:0007045) | 3.28713760 |
| 110 | nuclear pore complex assembly (GO:0051292) | 3.27178999 |
| 111 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.26061081 |
| 112 | protein localization to endosome (GO:0036010) | 3.24216982 |
| 113 | regulation of early endosome to late endosome transport (GO:2000641) | 3.20325064 |
| 114 | adherens junction assembly (GO:0034333) | 3.15264101 |
| 115 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.12610397 |
| 116 | cell-substrate junction assembly (GO:0007044) | 3.10227155 |
| 117 | fatty acid homeostasis (GO:0055089) | 2.99212378 |
| 118 | mitotic chromosome condensation (GO:0007076) | 2.99016724 |
| 119 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.92404471 |
| 120 | proline metabolic process (GO:0006560) | 2.91584117 |
| 121 | hemidesmosome assembly (GO:0031581) | 2.90012017 |
| 122 | embryonic process involved in female pregnancy (GO:0060136) | 2.89073121 |
| 123 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.88129522 |
| 124 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.87936142 |
| 125 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.86821142 |
| 126 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.84045548 |
| 127 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.82124537 |
| 128 | positive regulation of extracellular matrix organization (GO:1903055) | 2.81733904 |
| 129 | protein retention in ER lumen (GO:0006621) | 2.79114615 |
| 130 | negative regulation of lipid transport (GO:0032369) | 2.78583000 |
| 131 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.77232780 |
| 132 | COPII vesicle coating (GO:0048208) | 2.73898466 |
| 133 | tricarboxylic acid metabolic process (GO:0072350) | 2.73746313 |
| 134 | regulation of RNA export from nucleus (GO:0046831) | 2.72792319 |
| 135 | regulation of cholesterol metabolic process (GO:0090181) | 2.63830370 |
| 136 | glucose 6-phosphate metabolic process (GO:0051156) | 2.63698704 |
| 137 | vesicle coating (GO:0006901) | 2.61318595 |
| 138 | basement membrane organization (GO:0071711) | 2.55631940 |
| 139 | activation of Rac GTPase activity (GO:0032863) | 2.52844164 |
| 140 | triglyceride biosynthetic process (GO:0019432) | 2.52669535 |
| 141 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.52549821 |
| 142 | skin morphogenesis (GO:0043589) | 2.51642600 |
| 143 | oxaloacetate metabolic process (GO:0006107) | 2.49378306 |
| 144 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.48841514 |
| 145 | triglyceride metabolic process (GO:0006641) | 2.48563560 |
| 146 | cellular protein complex localization (GO:0034629) | 2.47840468 |
| 147 | sodium ion export (GO:0071436) | 2.47688182 |
| 148 | stress fiber assembly (GO:0043149) | 2.47118166 |
| 149 | nuclear pore organization (GO:0006999) | 2.46583502 |
| 150 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.46416877 |
| 151 | epithelial cell-cell adhesion (GO:0090136) | 2.45011312 |
| 152 | epoxygenase P450 pathway (GO:0019373) | 2.41551981 |
| 153 | acylglycerol biosynthetic process (GO:0046463) | 2.41160482 |
| 154 | neutral lipid biosynthetic process (GO:0046460) | 2.41160482 |
| 155 | intestinal absorption (GO:0050892) | 2.40562522 |
| 156 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.40162546 |
| 157 | surfactant homeostasis (GO:0043129) | 2.40130892 |
| 158 | mannose metabolic process (GO:0006013) | 2.38822595 |
| 159 | barbed-end actin filament capping (GO:0051016) | 2.38572578 |
| 160 | maternal placenta development (GO:0001893) | 2.37641806 |
| 161 | positive regulation of nuclease activity (GO:0032075) | 2.35763290 |
| 162 | negative regulation of cell size (GO:0045792) | 2.34916471 |
| 163 | acylglycerol metabolic process (GO:0006639) | 2.34125314 |
| 164 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.32960487 |
| 165 | regulation of histone H3-K27 methylation (GO:0061085) | 2.30356077 |
| 166 | neutral lipid metabolic process (GO:0006638) | 2.29953082 |
| 167 | response to mercury ion (GO:0046689) | 2.29878368 |
| 168 | linoleic acid metabolic process (GO:0043651) | 2.29130517 |
| 169 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.27481803 |
| 170 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.27232472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.42702089 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.31058349 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.50860869 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.90758205 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.65772044 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.57133069 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.22406307 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67900642 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.24793193 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.24254593 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.19089971 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50532031 |
| 13 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.46512376 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.08943761 |
| 15 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.01178309 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3639404 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.97372918 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93169302 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.93038836 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87991149 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85119715 |
| 22 | * MYC_22102868_ChIP-Seq_BL_Human | 1.83361270 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71155532 |
| 24 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.70896594 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67868479 |
| 26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61852768 |
| 27 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.60543289 |
| 28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58853390 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52875216 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.52523363 |
| 31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.51817635 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51624919 |
| 33 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49357882 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47069656 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45514014 |
| 36 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.42482459 |
| 37 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.41098436 |
| 38 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.39118520 |
| 39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37557178 |
| 40 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.33607259 |
| 41 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33004671 |
| 42 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32865011 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31561932 |
| 44 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31348743 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30052461 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29984830 |
| 47 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.29361784 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29245240 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27551647 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.26766212 |
| 51 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26201713 |
| 52 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.26201713 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25040705 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24016276 |
| 55 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23011078 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21508439 |
| 57 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21350849 |
| 58 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21296027 |
| 59 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21183470 |
| 60 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.19472996 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.19379398 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17649710 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17405832 |
| 64 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17012026 |
| 65 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15813027 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12745916 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10541212 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07678008 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06491030 |
| 70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06312927 |
| 71 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.06028402 |
| 72 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05698244 |
| 73 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03395481 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01214556 |
| 75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01199518 |
| 76 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01197878 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99765335 |
| 78 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.97787160 |
| 79 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97613054 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96656389 |
| 81 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96313164 |
| 82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93855274 |
| 83 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93580984 |
| 84 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93510255 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92245471 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91669518 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88744632 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87281291 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85076142 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84499055 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84330835 |
| 92 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.81462546 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81214329 |
| 94 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78142040 |
| 95 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77975669 |
| 96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.77659215 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77584564 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77517606 |
| 99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77202368 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76158000 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76076924 |
| 102 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.75088946 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73742256 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73563786 |
| 105 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.73361448 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73201146 |
| 107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.72461909 |
| 108 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.72280965 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71130824 |
| 110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.71123905 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70192689 |
| 112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.69929539 |
| 113 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.69911455 |
| 114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69541469 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67893486 |
| 116 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67687201 |
| 117 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.66831187 |
| 118 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66306478 |
| 119 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64274060 |
| 120 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.63745307 |
| 121 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.63745307 |
| 122 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.63706653 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63107082 |
| 124 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62877832 |
| 125 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.62517805 |
| 126 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62163974 |
| 127 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.61654164 |
| 128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61598811 |
| 129 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.60684296 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59371806 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59063574 |
| 132 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57159094 |
| 133 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.56109140 |
| 134 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55787251 |
| 135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55374607 |
| 136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55374607 |
| 137 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55184809 |
| 138 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53171295 |
| 139 | ATF3_27146783_Chip-Seq_COLON_Human | 0.53160213 |
| 140 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.52658258 |
| 141 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.52096442 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.51803659 |
| 143 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.51423678 |
| 144 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.51106740 |
| 145 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.51047477 |
| 146 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.50553116 |
| 147 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.50533188 |
| 148 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.50037992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.44575695 |
| 2 | MP0005360_urolithiasis | 6.66774021 |
| 3 | MP0005365_abnormal_bile_salt | 5.57321092 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.48978755 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.33693075 |
| 6 | * MP0010329_abnormal_lipoprotein_level | 3.72322293 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.67758452 |
| 8 | MP0003252_abnormal_bile_duct | 3.50823171 |
| 9 | MP0009840_abnormal_foam_cell | 3.24324226 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 3.15089909 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.81109020 |
| 12 | MP0005409_darkened_coat_color | 2.60934258 |
| 13 | MP0005083_abnormal_biliary_tract | 2.60100370 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.55794719 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.53345262 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.52339037 |
| 17 | MP0005332_abnormal_amino_acid | 2.48173874 |
| 18 | MP0005670_abnormal_white_adipose | 2.47904115 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.33988464 |
| 20 | * MP0000609_abnormal_liver_physiology | 2.26612646 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 2.24529500 |
| 22 | MP0003195_calcinosis | 2.10391635 |
| 23 | MP0008260_abnormal_autophagy | 1.96862762 |
| 24 | MP0004130_abnormal_muscle_cell | 1.95599512 |
| 25 | MP0004233_abnormal_muscle_weight | 1.89739470 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.82596202 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.81144213 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.81094117 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.77939535 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.72392439 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62525234 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.53229410 |
| 33 | MP0003868_abnormal_feces_composition | 1.50788202 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.50451253 |
| 35 | MP0001764_abnormal_homeostasis | 1.48806082 |
| 36 | MP0005501_abnormal_skin_physiology | 1.43560080 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.41856201 |
| 38 | MP0003186_abnormal_redox_activity | 1.40598712 |
| 39 | MP0001849_ear_inflammation | 1.36870999 |
| 40 | MP0003091_abnormal_cell_migration | 1.34256040 |
| 41 | MP0004272_abnormal_basement_membrane | 1.33876087 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.33191195 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.32411665 |
| 44 | * MP0002971_abnormal_brown_adipose | 1.29911353 |
| 45 | MP0002254_reproductive_system_inflammat | 1.24832621 |
| 46 | MP0006138_congestive_heart_failure | 1.24192500 |
| 47 | MP0009697_abnormal_copulation | 1.21217144 |
| 48 | MP0000598_abnormal_liver_morphology | 1.20220307 |
| 49 | MP0003011_delayed_dark_adaptation | 1.18377318 |
| 50 | MP0005451_abnormal_body_composition | 1.15301573 |
| 51 | * MP0005334_abnormal_fat_pad | 1.14596075 |
| 52 | MP0001915_intracranial_hemorrhage | 1.13231296 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.12869806 |
| 54 | MP0005375_adipose_tissue_phenotype | 1.12758707 |
| 55 | MP0001661_extended_life_span | 1.12016979 |
| 56 | MP0005647_abnormal_sex_gland | 1.09625929 |
| 57 | MP0001730_embryonic_growth_arrest | 1.08118576 |
| 58 | MP0001216_abnormal_epidermal_layer | 1.08091700 |
| 59 | MP0004381_abnormal_hair_follicle | 1.08077177 |
| 60 | MP0002098_abnormal_vibrissa_morphology | 1.07644404 |
| 61 | MP0000579_abnormal_nail_morphology | 1.07191596 |
| 62 | MP0009763_increased_sensitivity_to | 1.05983999 |
| 63 | MP0010678_abnormal_skin_adnexa | 1.04789826 |
| 64 | MP0000604_amyloidosis | 1.02558489 |
| 65 | MP0003690_abnormal_glial_cell | 0.99013594 |
| 66 | MP0010630_abnormal_cardiac_muscle | 0.97881158 |
| 67 | MP0009764_decreased_sensitivity_to | 0.96239185 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 0.95686007 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 0.95293673 |
| 70 | MP0002896_abnormal_bone_mineralization | 0.94115618 |
| 71 | MP0000467_abnormal_esophagus_morphology | 0.93965444 |
| 72 | MP0004087_abnormal_muscle_fiber | 0.93636875 |
| 73 | MP0000678_abnormal_parathyroid_gland | 0.92184177 |
| 74 | * MP0002078_abnormal_glucose_homeostasis | 0.91878488 |
| 75 | MP0008469_abnormal_protein_level | 0.90745265 |
| 76 | MP0000747_muscle_weakness | 0.90632424 |
| 77 | MP0003941_abnormal_skin_development | 0.90048195 |
| 78 | MP0005535_abnormal_body_temperature | 0.89789440 |
| 79 | MP0005621_abnormal_cell_physiology | 0.89064750 |
| 80 | MP0010307_abnormal_tumor_latency | 0.88485401 |
| 81 | MP0000627_abnormal_mammary_gland | 0.88408582 |
| 82 | MP0000858_altered_metastatic_potential | 0.88331589 |
| 83 | MP0000377_abnormal_hair_follicle | 0.88238387 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.88195077 |
| 85 | MP0003724_increased_susceptibility_to | 0.86501629 |
| 86 | * MP0009115_abnormal_fat_cell | 0.86149718 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 0.86038125 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.85031621 |
| 89 | MP0002086_abnormal_extraembryonic_tissu | 0.84205471 |
| 90 | MP0002269_muscular_atrophy | 0.83867246 |
| 91 | * MP0009642_abnormal_blood_homeostasis | 0.83830971 |
| 92 | MP0010368_abnormal_lymphatic_system | 0.82227527 |
| 93 | MP0003300_gastrointestinal_ulcer | 0.80479599 |
| 94 | MP0008438_abnormal_cutaneous_collagen | 0.80197671 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.79475976 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.78892877 |
| 97 | MP0003111_abnormal_nucleus_morphology | 0.78877142 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.77027652 |
| 99 | MP0004858_abnormal_nervous_system | 0.77021221 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.76712101 |
| 101 | MP0002009_preneoplasia | 0.75889147 |
| 102 | MP0000762_abnormal_tongue_morphology | 0.75214057 |
| 103 | MP0003984_embryonic_growth_retardation | 0.75054509 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.74746613 |
| 105 | MP0002796_impaired_skin_barrier | 0.74669771 |
| 106 | MP0009931_abnormal_skin_appearance | 0.74542889 |
| 107 | MP0001672_abnormal_embryogenesis/_devel | 0.74183533 |
| 108 | MP0005380_embryogenesis_phenotype | 0.74183533 |
| 109 | MP0000350_abnormal_cell_proliferation | 0.73792990 |
| 110 | * MP0002970_abnormal_white_adipose | 0.73323514 |
| 111 | * MP0005448_abnormal_energy_balance | 0.72719061 |
| 112 | MP0000462_abnormal_digestive_system | 0.72634217 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.72479848 |
| 114 | MP0002088_abnormal_embryonic_growth/wei | 0.71810837 |
| 115 | MP0001756_abnormal_urination | 0.71073621 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.70518037 |
| 117 | MP0004808_abnormal_hematopoietic_stem | 0.70115543 |
| 118 | MP0000920_abnormal_myelination | 0.69465528 |
| 119 | MP0000733_abnormal_muscle_development | 0.67742408 |
| 120 | MP0002396_abnormal_hematopoietic_system | 0.66742567 |
| 121 | MP0005408_hypopigmentation | 0.63485127 |
| 122 | MP0005266_abnormal_metabolism | 0.62074659 |
| 123 | MP0003436_decreased_susceptibility_to | 0.61436094 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.61143639 |
| 125 | MP0001881_abnormal_mammary_gland | 0.60019681 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.56756800 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.55149415 |
| 128 | MP0002060_abnormal_skin_morphology | 0.52813404 |
| 129 | MP0005220_abnormal_exocrine_pancreas | 0.51793644 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.51609901 |
| 131 | MP0003329_amyloid_beta_deposits | 0.51445754 |
| 132 | MP0000249_abnormal_blood_vessel | 0.51086840 |
| 133 | MP0000003_abnormal_adipose_tissue | 0.50334402 |
| 134 | MP0003075_altered_response_to | 0.49842563 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.48863192 |
| 136 | MP0005275_abnormal_skin_tensile | 0.48386804 |
| 137 | MP0004264_abnormal_extraembryonic_tissu | 0.47920418 |
| 138 | MP0002166_altered_tumor_susceptibility | 0.47352697 |
| 139 | MP0008873_increased_physiological_sensi | 0.45929140 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.45042373 |
| 141 | MP0001853_heart_inflammation | 0.44764673 |
| 142 | * MP0003953_abnormal_hormone_level | 0.44439786 |
| 143 | MP0009672_abnormal_birth_weight | 0.44343677 |
| 144 | MP0000639_abnormal_adrenal_gland | 0.41702958 |
| 145 | MP0005164_abnormal_response_to | 0.40436362 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.40369932 |
| 147 | MP0005023_abnormal_wound_healing | 0.39382116 |
| 148 | MP0002168_other_aberrant_phenotype | 0.38997576 |
| 149 | MP0004147_increased_porphyrin_level | 0.38549277 |
| 150 | MP0001845_abnormal_inflammatory_respons | 0.38054323 |
| 151 | MP0006035_abnormal_mitochondrial_morpho | 0.38001769 |
| 152 | MP0005166_decreased_susceptibility_to | 0.37403508 |
| 153 | MP0004947_skin_inflammation | 0.36741160 |
| 154 | * MP0005452_abnormal_adipose_tissue | 0.35548267 |
| 155 | MP0008874_decreased_physiological_sensi | 0.34843993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.56358421 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.49633103 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.17797551 |
| 4 | Xanthomatosis (HP:0000991) | 6.00444339 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.65908130 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.63713131 |
| 7 | Complement deficiency (HP:0004431) | 5.35376228 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.25143535 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.21439529 |
| 10 | Hyperammonemia (HP:0001987) | 4.57549700 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.55208183 |
| 12 | Epidermoid cyst (HP:0200040) | 4.54349245 |
| 13 | Hyperglycinuria (HP:0003108) | 4.46201183 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.33284025 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.30971746 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.30971746 |
| 17 | Ketosis (HP:0001946) | 4.27758230 |
| 18 | Hyperglycinemia (HP:0002154) | 4.20890500 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.20790706 |
| 20 | Joint hemorrhage (HP:0005261) | 4.16079649 |
| 21 | Hypoglycemic coma (HP:0001325) | 4.15402073 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.04980940 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.97793288 |
| 24 | Abnormality of complement system (HP:0005339) | 3.90488020 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.68594180 |
| 26 | Fat malabsorption (HP:0002630) | 3.66316933 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.65465459 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.64569745 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.64173094 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.50440329 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.40154265 |
| 32 | Abnormality of methionine metabolism (HP:0010901) | 3.35888268 |
| 33 | Myocardial infarction (HP:0001658) | 3.31485706 |
| 34 | Ketoacidosis (HP:0001993) | 3.22610881 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.02753326 |
| 36 | Hyperbilirubinemia (HP:0002904) | 2.92844067 |
| 37 | Asymmetry of the thorax (HP:0001555) | 2.90431008 |
| 38 | Skin nodule (HP:0200036) | 2.86735857 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.81342399 |
| 40 | Protrusio acetabuli (HP:0003179) | 2.78977381 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.78061847 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.78056329 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.78056329 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77966022 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.77041398 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 2.76277833 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.71021076 |
| 48 | Flat acetabular roof (HP:0003180) | 2.70765732 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.67030737 |
| 50 | Steatorrhea (HP:0002570) | 2.65365653 |
| 51 | Metabolic acidosis (HP:0001942) | 2.64774518 |
| 52 | Hypertriglyceridemia (HP:0002155) | 2.62359636 |
| 53 | Acanthocytosis (HP:0001927) | 2.59775516 |
| 54 | Spastic diplegia (HP:0001264) | 2.58873120 |
| 55 | Back pain (HP:0003418) | 2.58052385 |
| 56 | Vertebral compression fractures (HP:0002953) | 2.50770906 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.48862460 |
| 58 | Insidious onset (HP:0003587) | 2.47787681 |
| 59 | Termporal pattern (HP:0011008) | 2.47787681 |
| 60 | Abnormality of proline metabolism (HP:0010907) | 2.43172392 |
| 61 | Hydroxyprolinuria (HP:0003080) | 2.43172392 |
| 62 | Hyperacusis (HP:0010780) | 2.42084952 |
| 63 | Spontaneous abortion (HP:0005268) | 2.41392675 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.40422692 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.37630539 |
| 66 | Pancreatitis (HP:0001733) | 2.36093489 |
| 67 | Lethargy (HP:0001254) | 2.34042613 |
| 68 | Esophageal varix (HP:0002040) | 2.33921422 |
| 69 | Amyloidosis (HP:0011034) | 2.32058992 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.29773258 |
| 71 | Ankyloglossia (HP:0010296) | 2.29594068 |
| 72 | Cholelithiasis (HP:0001081) | 2.28477119 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28232302 |
| 74 | Vascular calcification (HP:0004934) | 2.26624045 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.24704556 |
| 76 | Right ventricular cardiomyopathy (HP:0011663) | 2.21520789 |
| 77 | Dysmetric saccades (HP:0000641) | 2.21433722 |
| 78 | Gingival bleeding (HP:0000225) | 2.20071564 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.19729795 |
| 80 | Cholecystitis (HP:0001082) | 2.19729795 |
| 81 | Abnormal cartilage morphology (HP:0002763) | 2.19332760 |
| 82 | Glomerulonephritis (HP:0000099) | 2.18490868 |
| 83 | Myoglobinuria (HP:0002913) | 2.17694331 |
| 84 | Hyperparathyroidism (HP:0000843) | 2.16235111 |
| 85 | Malnutrition (HP:0004395) | 2.14461529 |
| 86 | Menorrhagia (HP:0000132) | 2.14015426 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.12952934 |
| 88 | Generalized aminoaciduria (HP:0002909) | 2.12748047 |
| 89 | Cerebral aneurysm (HP:0004944) | 2.11178490 |
| 90 | Ulnar bowing (HP:0003031) | 2.09623859 |
| 91 | Late onset (HP:0003584) | 2.09040135 |
| 92 | Abnormality of the Achilles tendon (HP:0005109) | 2.08742510 |
| 93 | Cardiovascular calcification (HP:0011915) | 2.05374771 |
| 94 | Irritability (HP:0000737) | 2.05272427 |
| 95 | Brushfield spots (HP:0001088) | 2.03878764 |
| 96 | Neurofibrillary tangles (HP:0002185) | 2.03417239 |
| 97 | Gout (HP:0001997) | 2.02399713 |
| 98 | Insomnia (HP:0100785) | 2.00958725 |
| 99 | Abnormality of carpal bone ossification (HP:0006257) | 2.00648829 |
| 100 | Neonatal onset (HP:0003623) | 2.00192757 |
| 101 | Cerebral edema (HP:0002181) | 1.98867630 |
| 102 | Osteolytic defects of the hand bones (HP:0009699) | 1.97376677 |
| 103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97376677 |
| 104 | Vomiting (HP:0002013) | 1.97220328 |
| 105 | Mitral stenosis (HP:0001718) | 1.97023292 |
| 106 | Achilles tendon contracture (HP:0001771) | 1.95749690 |
| 107 | Oligomenorrhea (HP:0000876) | 1.95227313 |
| 108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94676137 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 1.94234782 |
| 110 | Increased connective tissue (HP:0009025) | 1.94135109 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92016850 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 1.91863842 |
| 113 | Exercise-induced myalgia (HP:0003738) | 1.91734558 |
| 114 | Advanced eruption of teeth (HP:0006288) | 1.91103727 |
| 115 | Premature rupture of membranes (HP:0001788) | 1.90835396 |
| 116 | Polycythemia (HP:0001901) | 1.90452261 |
| 117 | Arterial tortuosity (HP:0005116) | 1.89707707 |
| 118 | Acanthosis nigricans (HP:0000956) | 1.88755703 |
| 119 | Nephritis (HP:0000123) | 1.87987389 |
| 120 | Nausea (HP:0002018) | 1.87114350 |
| 121 | Poikilocytosis (HP:0004447) | 1.86629668 |
| 122 | Increased mean platelet volume (HP:0011877) | 1.85986503 |
| 123 | Thrombophlebitis (HP:0004418) | 1.85925753 |
| 124 | Spinal cord lesions (HP:0100561) | 1.85620352 |
| 125 | Syringomyelia (HP:0003396) | 1.85620352 |
| 126 | Hyperglycemia (HP:0003074) | 1.85321449 |
| 127 | Rhabdomyolysis (HP:0003201) | 1.84788286 |
| 128 | Distal lower limb muscle weakness (HP:0009053) | 1.83625586 |
| 129 | Abnormality of the gallbladder (HP:0005264) | 1.82435204 |
| 130 | Pigmentary retinal degeneration (HP:0001146) | 1.82238701 |
| 131 | Elevated hepatic transaminases (HP:0002910) | 1.81715886 |
| 132 | Abnormality of the gastric mucosa (HP:0004295) | 1.81644406 |
| 133 | Abnormal ossification of hand bones (HP:0005921) | 1.81164116 |
| 134 | Thin bony cortex (HP:0002753) | 1.80138849 |
| 135 | J-shaped sella turcica (HP:0002680) | 1.78391011 |
| 136 | Neonatal death (HP:0003811) | 1.78049645 |
| 137 | Reticulocytosis (HP:0001923) | 1.77775274 |
| 138 | Abnormality of oral frenula (HP:0000190) | 1.75956859 |
| 139 | Abnormal tarsal ossification (HP:0008369) | 1.75605989 |
| 140 | Abnormal foot bone ossification (HP:0010675) | 1.74216106 |
| 141 | Wormian bones (HP:0002645) | 1.73682833 |
| 142 | Hypercortisolism (HP:0001578) | 1.73485280 |
| 143 | Abnormality of nail color (HP:0100643) | 1.73211824 |
| 144 | Vascular tortuosity (HP:0004948) | 1.71395701 |
| 145 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.68434989 |
| 146 | Broad face (HP:0000283) | 1.66542119 |
| 147 | Microglossia (HP:0000171) | 1.66385340 |
| 148 | Abdominal distention (HP:0003270) | 1.63804516 |
| 149 | Vertebral arch anomaly (HP:0008438) | 1.63068624 |
| 150 | Relative macrocephaly (HP:0004482) | 1.61576644 |
| 151 | Increased variability in muscle fiber diameter (HP:0003557) | 1.60491901 |
| 152 | Macroorchidism (HP:0000053) | 1.59806782 |
| 153 | Multiple lipomas (HP:0001012) | 1.57920050 |
| 154 | Aneurysm (HP:0002617) | 1.56512871 |
| 155 | Decreased motor nerve conduction velocity (HP:0003431) | 1.55838828 |
| 156 | Septate vagina (HP:0001153) | 1.55046226 |
| 157 | Abnormality of the salivary glands (HP:0010286) | 1.54959405 |
| 158 | Upper limb amyotrophy (HP:0009129) | 1.52970197 |
| 159 | Distal upper limb amyotrophy (HP:0007149) | 1.52970197 |
| 160 | Atrioventricular block (HP:0001678) | 1.51944506 |
| 161 | Hyporeflexia of lower limbs (HP:0002600) | 1.51863221 |
| 162 | Subacute progressive viral hepatitis (HP:0006572) | 1.51106127 |
| 163 | Heterotopia (HP:0002282) | 1.50181862 |
| 164 | Bone pain (HP:0002653) | 1.49750126 |
| 165 | Spinal rigidity (HP:0003306) | 1.49666801 |
| 166 | Mitral regurgitation (HP:0001653) | 1.49422811 |
| 167 | Progressive external ophthalmoplegia (HP:0000590) | 1.49067574 |
| 168 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.48584464 |
| 169 | Abnormality of glycolysis (HP:0004366) | 1.48434231 |
| 170 | Micronodular cirrhosis (HP:0001413) | 1.48230361 |
| 171 | Overlapping toe (HP:0001845) | 1.48168793 |
| 172 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.47818814 |
| 173 | Hammertoe (HP:0001765) | 1.47468970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.59554924 |
| 2 | SIK1 | 4.17346852 |
| 3 | TRIB3 | 3.88318664 |
| 4 | ERN1 | 3.87488153 |
| 5 | PRPF4B | 3.19460161 |
| 6 | FGFR4 | 3.18955267 |
| 7 | PKN2 | 2.97078816 |
| 8 | LATS2 | 2.89743777 |
| 9 | CAMK1D | 2.86485228 |
| 10 | CDK12 | 2.83095054 |
| 11 | SMG1 | 2.80616157 |
| 12 | MST1R | 2.46276297 |
| 13 | SCYL2 | 2.25670803 |
| 14 | TAOK3 | 2.20622683 |
| 15 | INSRR | 1.97538594 |
| 16 | FLT3 | 1.94935000 |
| 17 | CAMK1G | 1.93826125 |
| 18 | EPHA2 | 1.84784221 |
| 19 | PTK6 | 1.75150747 |
| 20 | EPHB1 | 1.69558662 |
| 21 | RIPK1 | 1.68013545 |
| 22 | FRK | 1.59869532 |
| 23 | FGFR2 | 1.59514532 |
| 24 | LATS1 | 1.52878773 |
| 25 | MAP2K3 | 1.47544433 |
| 26 | MAP3K10 | 1.46903542 |
| 27 | ERBB4 | 1.43370983 |
| 28 | MAPK11 | 1.41222917 |
| 29 | EIF2AK1 | 1.39948900 |
| 30 | TYK2 | 1.39298327 |
| 31 | PRKAA2 | 1.39265877 |
| 32 | RPS6KB2 | 1.31120524 |
| 33 | MET | 1.30195408 |
| 34 | NEK9 | 1.29579142 |
| 35 | TGFBR2 | 1.26531178 |
| 36 | MAP3K13 | 1.25644835 |
| 37 | CDK6 | 1.24490737 |
| 38 | PAK4 | 1.23569750 |
| 39 | JAK2 | 1.23525194 |
| 40 | PIK3CG | 1.21473206 |
| 41 | MAP3K7 | 1.18049643 |
| 42 | MAP2K4 | 1.14842610 |
| 43 | TIE1 | 1.10739350 |
| 44 | PDK3 | 1.08639005 |
| 45 | PDK4 | 1.08639005 |
| 46 | JAK1 | 1.07549106 |
| 47 | FGFR3 | 1.04960742 |
| 48 | MAP3K9 | 1.04375366 |
| 49 | EEF2K | 1.03546885 |
| 50 | MAP4K1 | 1.00242820 |
| 51 | NEK6 | 0.99023014 |
| 52 | TBK1 | 0.96556593 |
| 53 | ARAF | 0.95740750 |
| 54 | GRK6 | 0.93693182 |
| 55 | LRRK2 | 0.89769702 |
| 56 | KDR | 0.86419967 |
| 57 | KSR1 | 0.83119366 |
| 58 | LMTK2 | 0.82208974 |
| 59 | TAOK2 | 0.82160794 |
| 60 | MAP3K3 | 0.81133918 |
| 61 | ABL2 | 0.79842514 |
| 62 | CDK4 | 0.79548549 |
| 63 | CSK | 0.79517712 |
| 64 | GSK3A | 0.78250288 |
| 65 | TTN | 0.77372331 |
| 66 | TESK1 | 0.75513627 |
| 67 | PDPK1 | 0.75089721 |
| 68 | MAP3K8 | 0.74715866 |
| 69 | NTRK1 | 0.74416681 |
| 70 | CSF1R | 0.72192301 |
| 71 | DAPK2 | 0.71274453 |
| 72 | PRKAA1 | 0.70426711 |
| 73 | STK38 | 0.69516463 |
| 74 | DMPK | 0.69473077 |
| 75 | PDGFRB | 0.69390438 |
| 76 | PRKG2 | 0.69065142 |
| 77 | AKT2 | 0.68867979 |
| 78 | PDK2 | 0.68614242 |
| 79 | PBK | 0.68404136 |
| 80 | MELK | 0.68281070 |
| 81 | CDK7 | 0.68030368 |
| 82 | RET | 0.67853338 |
| 83 | PIK3CA | 0.67448153 |
| 84 | PDGFRA | 0.67329060 |
| 85 | TRPM7 | 0.66571956 |
| 86 | MTOR | 0.66554792 |
| 87 | STK38L | 0.66149662 |
| 88 | MAPK4 | 0.65421670 |
| 89 | TYRO3 | 0.65096689 |
| 90 | PRKD3 | 0.64810292 |
| 91 | BMX | 0.64117646 |
| 92 | MAPK12 | 0.63686464 |
| 93 | MAP3K11 | 0.63677981 |
| 94 | JAK3 | 0.62977417 |
| 95 | DDR2 | 0.62056778 |
| 96 | CDK9 | 0.61587891 |
| 97 | PDK1 | 0.59284421 |
| 98 | PRKACG | 0.58778200 |
| 99 | BRD4 | 0.58550050 |
| 100 | STK3 | 0.57681978 |
| 101 | TTK | 0.57194158 |
| 102 | ICK | 0.57054437 |
| 103 | MAPKAPK3 | 0.56006362 |
| 104 | EPHA3 | 0.55255471 |
| 105 | YES1 | 0.53172321 |
| 106 | SIK3 | 0.53128653 |
| 107 | BRAF | 0.51894525 |
| 108 | RPS6KB1 | 0.51860957 |
| 109 | NME2 | 0.50164344 |
| 110 | SGK3 | 0.50056152 |
| 111 | RAF1 | 0.49336416 |
| 112 | ERBB2 | 0.49333303 |
| 113 | PINK1 | 0.49224743 |
| 114 | ALK | 0.48995023 |
| 115 | ZAP70 | 0.48957693 |
| 116 | MAP2K1 | 0.48266768 |
| 117 | IGF1R | 0.47360032 |
| 118 | STK24 | 0.46322462 |
| 119 | KIT | 0.46267516 |
| 120 | MAPK10 | 0.44518491 |
| 121 | RPS6KA2 | 0.44397380 |
| 122 | MAP3K14 | 0.44171726 |
| 123 | MAP3K2 | 0.43955547 |
| 124 | PTK2 | 0.43075557 |
| 125 | ILK | 0.41843465 |
| 126 | MAP2K2 | 0.41606021 |
| 127 | PRKD1 | 0.41593631 |
| 128 | STK10 | 0.41247074 |
| 129 | BTK | 0.41163459 |
| 130 | WNK1 | 0.39245223 |
| 131 | MAP3K6 | 0.38972715 |
| 132 | CSNK1G1 | 0.37338309 |
| 133 | FGFR1 | 0.37308931 |
| 134 | NEK2 | 0.36670457 |
| 135 | MOS | 0.35817241 |
| 136 | CDC42BPA | 0.35422060 |
| 137 | PRKCZ | 0.34796749 |
| 138 | DYRK1B | 0.34038779 |
| 139 | PAK2 | 0.32853864 |
| 140 | CLK1 | 0.32610835 |
| 141 | MAP2K6 | 0.32390991 |
| 142 | ITK | 0.32064061 |
| 143 | PRKCQ | 0.31683294 |
| 144 | IKBKE | 0.31555614 |
| 145 | IRAK3 | 0.31405642 |
| 146 | KSR2 | 0.31037762 |
| 147 | EGFR | 0.30452029 |
| 148 | PRKCH | 0.30353318 |
| 149 | MAP3K1 | 0.29708189 |
| 150 | MARK2 | 0.29402958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.98483976 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.80571501 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05695350 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81358717 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76367505 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74970009 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.67731324 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61153045 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60651966 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53351481 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.49592778 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46080660 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.41903433 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26979516 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.25387521 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06619156 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06006492 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.05935828 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.05145135 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94178542 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86103590 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84683913 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78444667 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75722386 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72475481 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72351629 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64465534 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.64409746 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.59019234 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.54632251 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53943534 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.53221893 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.52967364 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50031202 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.49820916 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46931950 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41797788 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.40195617 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.39306962 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38251702 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.37998834 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35607919 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35493127 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34475468 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.33937833 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32586282 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31016138 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.26679109 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.26326523 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 1.26074425 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22953661 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20029004 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18097450 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17646054 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13243585 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.11503612 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09524728 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.08130217 |
| 59 | Glioma_Homo sapiens_hsa05214 | 1.08086607 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06870973 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04814796 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 1.01462866 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 1.00264101 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99781813 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98362325 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.96584749 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96571839 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95274782 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94977344 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93374993 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93171758 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.91222996 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91079280 |
| 74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87981271 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.87396354 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86063332 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.81883747 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81808335 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81217526 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81203485 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80174712 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79736574 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79729060 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78440444 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74815809 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74537017 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74175845 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73788412 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71916532 |
| 90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69005170 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67782788 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67494146 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65383995 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64877356 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63736109 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63048517 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62172013 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60126016 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59085963 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58771271 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56898296 |
| 102 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54701989 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52908565 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.52850381 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50451117 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49871041 |
| 107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49274410 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47567961 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39943217 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38742463 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35414805 |
| 112 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35337908 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35176125 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34102071 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32411842 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29084716 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.25091606 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23676820 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22359413 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14507376 |
| 121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13256854 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05388528 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04316048 |
| 124 | Pertussis_Homo sapiens_hsa05133 | -0.1628139 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1618325 |
| 126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1589930 |
| 127 | Lysosome_Homo sapiens_hsa04142 | -0.1500759 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1392652 |
| 129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1321126 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1294952 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1249033 |
| 132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1224548 |
| 133 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1219896 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | -0.1018923 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0960375 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0869198 |
| 137 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0762326 |
| 138 | Hepatitis C_Homo sapiens_hsa05160 | -0.0723928 |
| 139 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0708398 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0623159 |

